InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors

July 2, 2019

Read More »

InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

May 15, 2019

Read More »

InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019

May 8, 2019

Read More »

InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology

March 18, 2019

Read More »

InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program

March 13, 2019

Read More »

InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019

March 12, 2019

Read More »

InMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board

March 6, 2019

Read More »

InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

February 12, 2019

Read More »

InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019

February 5, 2019

Read More »

InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer

January 11, 2019

Read More »

InMed Pharmaceuticals to Present at Biotech Showcase 2019 on January 9, 2019

January 3, 2019

Read More »

InMed Pharmaceuticals Receives Funding from the Government of Canada to Support Development of Novel Cannabinoid Biosynthesis Program

December 4, 2018

Read More »

InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

November 12, 2018

Read More »

InMed Pharmaceuticals to Report First Quarter Fiscal 2019 Financial Results and Business Update on November 12, 2018

November 5, 2018

Read More »

InMed Pharmaceuticals Appoints Michael Woudenberg as Vice President, Chemistry, Manufacturing, and Controls

November 5, 2018

Read More »

InMed Pharmaceuticals to Present at BIO Investor Forum on October 17, 2018

October 10, 2018

Read More »

InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada for Cannabinoid Biofermentation Process Development and Scale-Up

October 3, 2018

Read More »

InMed Pharmaceuticals Files PCT Patent Application for the Treatment of Pain with Cannabinoids

September 25, 2018

Read More »

InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update

September 13, 2018

Read More »

InMed Pharmaceuticals Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work

September 11, 2018

Read More »